Electroconvulsive therapy (ECT) has long been a contentious treatment modality within the field of psychiatry, utilized primarily for severe cases of depression and other refractory mental health conditions. The procedure involves the administration of controlled electrical currents to the brain while the patient is under general anesthesia, provoking a therapeutic seizure typically induced across multiple sessions. Although practiced globally, its safety and efficacy remain subjects of fierce debate. A landmark international survey published in Psychology and Psychotherapy: Theory, Research and Practice recently gathered unprecedented insights into the perspectives of relatives and close acquaintances of ECT recipients. This research challenges prevailing clinical narratives about the treatment’s benign profile and therapeutic benefits.
The extensive study enlisted 286 participants from 22 countries, all of whom had firsthand experience observing the consequences of ECT on their loved ones. The results paint a complex picture: while 45% of respondents acknowledged some clinical improvement in the symptoms that led to ECT administration, a striking 42% reported a worsening of these very issues. This divide underscores the variability in patient outcomes and calls into question assumptions of guaranteed efficacy conveyed during treatment consent procedures.
Quality of life assessments provided one of the study’s most compelling revelations. A majority of 61% of relatives and friends perceived a deterioration in overall quality of life following ECT treatment, in stark contrast to only 32% who observed any improvement. This effect transcends mere symptom relief, suggesting widespread disruptions to functionality, personal autonomy, and emotional wellbeing that are often underreported or insufficiently quantified in clinical studies.
Cognitive impairments emerged as a profound cause for concern. Most respondents observed significant memory deficits in their ECT-treated relatives, frequently persisting beyond three years. Such prolonged amnestic syndromes challenge the clinical rhetoric minimizing cognitive side effects, especially given that memory loss is sometimes dismissed as a confounding effect of the underlying psychiatric disorder rather than a treatment sequela.
Beyond memory, the survey identified an array of additional adverse effects commonly endured by patients post-ECT. More than half of those surveyed reported their loved ones suffering from concentration difficulties, persistent fatigue, emotional blunting, diminished independence, and strained interpersonal relationships. These symptoms collectively elucidate the multi-dimensional impact of ECT that extends well beyond the neurochemical domain targeted by the intervention.
An ethically charged question posed to the relatives and friends encapsulated their overall stance: “Would you want to have ECT yourself if a psychiatrist recommended it?” The answer was a resounding “no” from 72% of participants. This personal aversion mirrors the growing skepticism emerging from this broader, non-clinical cohort directly affected by ECT outcomes.
Juxtaposing these findings with self-reported experiences from ECT recipients themselves, as documented in previous research, reveals a striking consistency. The alignment between patient and family feedback validates the reported adverse effects and counters the tendency within psychiatric practice to attribute symptoms such as cognitive deficits and emotional blunting solely to the persistence of depressive pathology.
The study’s corresponding author, Dr. John Read of the University of East London, emphasizes the need for critical appraisal of ECT’s risk-benefit profile. According to Dr. Read, the act of “applying electricity to the human brain in sufficient dosages to cause seizures is, unsurprisingly, a high-risk procedure with limited efficacy.” This assessment underscores the urgency for clinicians and policymakers to revisit the therapeutic justifications and consent standards surrounding ECT.
From a technical standpoint, ECT’s mechanism of action remains incompletely understood, though it is believed to involve broad neuromodulatory effects triggered by the induced seizure. Historically celebrated for rapid symptom relief in life-threatening depression, the therapy’s side effects, particularly in domains such as neurocognitive function, require more robust, nuanced longitudinal analysis integrating patient and familial perspectives.
While the study’s non-randomized sampling methodology introduces potential biases, it represents the largest global collection of qualitative data from relatives and friends of ECT recipients to date. This expansive reach lends significant weight to its conclusions, inviting reevaluation of ECT’s status within psychiatric treatment algorithms.
Furthermore, the findings spotlight an urgent need for enhanced informed consent processes that transparently communicate the breadth of potential risks and realistic prognoses. The disparity between clinical optimism and lived experience accentuates ethical imperatives to prioritize patient autonomy and safeguard rights when considering ECT.
In summary, this international survey disrupts entrenched narratives portraying ECT as predominantly safe and effective. The combined testimony from patients and their close connections reveals a complex landscape of often long-lasting adverse effects, limited therapeutic gains, and substantial declines in quality of life. This evidence should catalyze renewed discourse among mental health professionals, researchers, and patient advocacy groups striving to optimize psychiatric care pathways with minimal harm.
Given these revelations, future research must integrate comprehensive neuropsychological evaluations, standardized adverse effect monitoring, and multifaceted quality of life assessments. Only through such holistic studies can the psychiatric community responsibly weigh the role of ECT amidst advancing alternatives and evolving understandings of brain stimulation therapies.
Subject of Research: Electroconvulsive Therapy (ECT) and its effects as reported by relatives and friends of recipients.
Article Title: An international survey of the relatives and friends of electroconvulsive therapy recipients
News Publication Date: 22-Apr-2026
Web References:
Keywords: mental health, clinical psychology, adverse effects, informed consent, psychiatry, psychological science, social research
